Rasmus Borgquist: Silent Atherosclerosis is Far More Common Than Thought
Rasmus Borgquist, Medical Director, Head of Cardiovascular medicine at Novo Nordisk Foundation, shared a post on LinkedIn:
“A new study published today from the REACT initiative shows that silent atherosclerosis – the underlying cause of most cardiovascular disease – is far more common than previously thought, including among younger adults.
The study also provides a detailed picture of how atherosclerosis develops across adult life.
The findings were presented here at the European Society of Cardiology Congress and simultaneously published in The New England Journal of Medicine.
At the Novo Nordisk Foundation, we want to help reduce the burden of cardiometabolic diseases, including cardiovascular disease – and prevention is key to that goal.
The new knowledge from REACT, a Danish-Spanish research collaboration funded by the Foundation, provides an important foundation for investigating whether earlier and more targeted prevention strategies can reduce heart attacks, strokes, and other cardiovascular events later in life.
Congratulations to Henning Bundgaard, Borja Ibanez, and the many researchers at Rigshospitalet and CNIC – Spanish National Center for Cardiovascular Research who have made this work possible.”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question